Versant Ventures Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 25
- Investments
- 458
- Portfolio
- 51
- Exits
- 208
Versant Ventures General Information
Description
Founded in 1999, Versant Ventures is a venture capital investment firm that is based in San Francisco, California. The firm prefers to invest in the manufacturing, life sciences, oncology, industrials, impact investing, and pharmaceuticals sectors.
Contact Information
Website
versantventures.com
Year Founded
1999
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
- One Sansome Street
- Suite 3630
- San Francisco, CA 94104
- United States
+1 (415) 000-0000
Versant Ventures Investments (458)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ventus Therapeutics | 09-Feb-2022 | Later Stage VC | 00000 | Drug Discovery | Generating Revenue | 0000000 00000 00.0 |
| 0000 0000000000000 | 02-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 0000000 0000000000 | 24-Nov-2021 | 00000 000000 | Drug Discovery | |||
| 00000000 000000000 | 14-Oct-2021 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | 00000 00000 00.0 |
| 00000 000000000000 | 09-Sep-2021 | 00000 00000 | 00000 | Biotechnology | Startup | 000000 00000000 00.0 |
| 000000 | 09-Sep-2021 | 00000 00000 | 0000 | Biotechnology | Startup | 000000 0000000 00.0 |
| 00000 000000000000 | 18-Aug-2021 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | 00000 0000000 00.0 |
| 0-00000 | 02-Aug-2021 | 00000 00000 | 00000 | Pharmaceuticals | Generating Revenue | 000000000 000000 00.0 |
| Turnstone Biologics | 14-Jul-2021 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue | 00000 00000 00.0 |
| Tempest Therapeutics | 28-Jun-2021 | PIPE | 0000 | Drug Discovery | Generating Revenue | 000000 0000000 00.0 |
Versant Ventures Exits (208)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Ivantis | 10-Jan-2022 | Merger/Acquisition | |
| 0000000 (000000000 | 26-Oct-2021 | 000 | 0000 |
| 00000 | 29-Sep-2021 | 0000000000: 000000 | |
| 00000000 000000000 | 01-Aug-2021 | 000000000000000000 | 00.00 |
| 0000000 0000000000 | 28-Jun-2021 | 0000000 000000 | |
| 00000000 000 | 25-Jun-2021 | 000 | 00000 |
| 00000 0000 0000000 | 24-Jun-2021 | 000 | 00000 |
| 0000000 0000000000 | 18-Jun-2021 | 000 | 00000 |
| Respicardia | 09-Apr-2021 | Merger/Acquisition | |
| VectivBio | 09-Apr-2021 | IPO | 00000 |
Versant Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Versant Ventures‘s full profile, request access.
Request a free trialVersant Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialVersant Ventures Team (67)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Robin Praeger | Chief Financial Officer & Managing Director | 0 | San Francisco, CA | ||
| Charles Warden | Co-Founder and Managing Director | 00 | 0 | 0 | San Francisco, CA |
| Barbara Lubash | Co-Founder & Managing Director | 00 | 0 | 0 | San Francisco, CA |
| Donald Milder | Co-Founder & Managing Director | 0 | 0 | 0 | San Francisco, CA |
| Rebecca Robertson | Co-Founder & Managing Director | 00 | 0 | 0 | San Francisco, CA |
Versant Ventures Co-Investors (182)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 12 | 0 | 0 |
|
|
| RA Capital Management | 00 | 0 | 00 |
|
|
| Alexandria Venture Investments | 0 | 0 | 0 |
|
|
| Logos Capital | 0 | 0 | 0 |
|
|
| Cormorant Asset Management | 0 | 0 |
|
|